InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the phase II results of orelabrutinib ...

Manipulating the immune system to treat cancer has generated phenomenal responses in some patients, including complete cures, ...

The U.S. atherosclerosis treatment market is driven by a high prevalence of cardiovascular diseases, pharmaceutical advancements, an aging population, lifestyle risks, and government health ...

The immune cells were at a 7 times higher ratio in lung samples from men than women, and may explain sex differences between ...

近日，华中科技大学武汉光电国家研究中心张智红教授团队在《表型组学（英文）（Phenomics）在线发表了题为“Modulating and Imaging Macrophage Reprogramming for Cancer ...

Researchers have identified YAP and TAZ as crucial regulators of macrophage-mediated pulmonary inflammation and fibrosis, ...

A discovery at Duke-NUS Medical School offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe.

(Nasdaq: CARM) has announced that Michael Klichinsky, PharmD, PhD, Co-founder and Chief Scientific Officer, will present at ...

2021年12月11日，山西医科大学第二医院心血管内科在Bioengineered（中科院四区 IF=4.2）期刊上在线发表题为 "Correlation between mechanism of oxidized-low density ...

Echinacea is a genus of flowering plants in the daisy family, Asteraceae, and has been used for centuries in traditional medicine.

Dr. Rousseau to lead clinical development as Pheast advances PHST001, a novel anti-CD24 macrophage checkpoint inhibitor, into ...

Following an admission to the authors’ centre with severe anaemia, duodenal biopsy confirmed the diagnosis of Whipple’s ...